Successful medical management of insulinoma with diazoxide for 27 years

Annabelle M Warren; Duncan J Topliss; Peter Shane Hamblin

doi:10.1530/EDM-20-0132

Endocrinology, Diabetes & Metabolism Case Reports (Oct 2020)

Successful medical management of insulinoma with diazoxide for 27 years

Annabelle M Warren,
Duncan J Topliss,
Peter Shane Hamblin

Affiliations

Annabelle M Warren: Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia
Duncan J Topliss: Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia; Monash University, Central Clinical School, Melbourne, Victoria, Australia
Peter Shane Hamblin: Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia; Monash University, Central Clinical School, Melbourne, Victoria, Australia; Department of Endocrinology and Diabetes, Western Health, Melbourne, Victoria, Australia; Department of Medicine, Western Clinical School, The University of Melbourne, Melbourne, Victoria, Australia

DOI: https://doi.org/10.1530/EDM-20-0132
Journal volume & issue: Vol. 1, no. 1
pp. 1 – 5

Abstract

Read online

Despite improvements in localisation techniques and surgical advances, some patients with insulinoma will not be cured by surgery or may not be suitable for surgery. Medical management with diazoxide is an option for such cases. This case report details 27 years of successful management of insulinoma using diazoxide. It has been effective and safe, with only minor adverse effects.

Published in Endocrinology, Diabetes & Metabolism Case Reports

ISSN: 2052-0573 (Online)
Publisher: Bioscientifica
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
Website: https://edm.bioscientifica.com/

About the journal

Abstract

Keywords